# Inveniam

> Inveniam is a VC fund in Barcelona backing Biopharma, Health Care and Life Science. See 4 investments, check sizes, portfolio. Updated Aug 2026.

- Type: VC Fund
- Location: Barcelona, Spain
- Total investments: 4
- Last investment: Jan 2023
- Lead investor: 0%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company/10497116/
- X (Twitter): https://www.twitter.com/massive_studio
- Website: http://inveniam-group.com/
- Facebook: https://www.facebook.com/massive-dynamic-103449616659095

Inveniam is a transaction and strategy advisory firm, with a strong focus in technology-based deals in Life Sciences and Resource Sustainability. Inveniam’s vision is to bridge the gap between technology originators and the market.Either serving the buy or the sell-side, Inveniam accompanies the client throughout the deal life cycle with a widearray of services, from opportunity scouting and assessment, all the way to commercialization, deal structuring and closing.Leveraging a diversified team across expertise and background, Inveniam offers a unique combination of skills and industry insight to support institutions, investors, start-ups and corporations with truly specialized advisory services. Inveniam is headquartered in Spain and Israel, and has an outstanding world reach through its alliances and collaborators. Together we ignite traction to your technology venture.

## Round sizes

| Stage | Round size |
| --- | --- |
| Seed | $568k–$1.1M |

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Biopharma | 1 | 25% |
| Health Care | 1 | 25% |
| Life Science | 1 | 25% |
| Therapeutics | 1 | 25% |
| Biotechnology | 1 | 25% |

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Seed | 2 | 50% |
| Grant | 1 | 25% |
| Funding Round | 1 | 25% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| NIMBLE Diagnostics | NIMBLE Diagnostics is a technological organization that develops and provides services related to biotechnology research activities. | $1.1M |  | Jan 19, 2023 |  |
| NIMBLE Diagnostics | NIMBLE Diagnostics is a technological organization that develops and provides services related to biotechnology research activities. | $1.1M | Grant | Jan 15, 2023 |  |
| NIMBLE Diagnostics | NIMBLE Diagnostics is a technological organization that develops and provides services related to biotechnology research activities. | $1.1M | Seed | Jan 15, 2023 |  |
| AtG Therapeutics | AtG is a spin-off company from the Bellvitge Biomedical Research Institute (IDIBELL) and the Catalan Institute of Oncology (ICO) in Barcelona that specialized in the discovery and development of new therapeutic techniques for cancer resistance to improve the lives of cancer patients. | $568.3K | Seed | Jul 21, 2022 |  |

4 of 4 investments shown.

## Co-investors
- [Grow Venture Partners](https://shizune.co/investors/profile/grow-venture-partners) — VC Fund, 3 deals together
- [Namarel Ventures](https://shizune.co/investors/profile/namarel-ventures) — VC Fund, 2 deals together
- [Blue Goose Capital](https://shizune.co/investors/profile/blue-goose-capital) — VC Fund, 1 deal together
- [WA4STEAM](https://shizune.co/investors/profile/wa4steam) — VC Fund, 1 deal together

## Similar investors

### Similar industry
- [SOSV](https://shizune.co/investors/profile/sosv) — VC Fund
- [ARCH Venture Partners](https://shizune.co/investors/profile/arch-venture-partners) — VC Fund
- [Alexandria Venture Investments](https://shizune.co/investors/profile/alexandria-venture-investments) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

### Similar country
- [ENISA](https://shizune.co/investors/profile/enisa-2) — VC Fund
- [Inveready](https://shizune.co/investors/profile/inveready-technology-investment-group) — VC Fund
- [Angels Capital](https://shizune.co/investors/profile/angels-capital) — VC Fund

## Featured in investor lists
- [Life Science Investors in Spain](https://shizune.co/investors/life-science-investors-spain)

## FAQ

### What does Inveniam invest in?

Inveniam invests primarily in Biopharma, Health Care and Life Science startups, most often at Seed and Grant stage. Most of the 4 investments tracked by Shizune back companies in Spain. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### What is Inveniam's check size?

Inveniam typically joins rounds of $568k–$1.1M at Seed. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Inveniam participates in.

### When did Inveniam last invest?

The most recent investment recorded for Inveniam closed in Jan 2023. Shizune tracks 4 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co